Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

Conditions

• Malignant Pleural Mesothelioma
• Unresectable Malignant Neoplasm

Interventions

• OTHER: Data collection

Sponsor

Groupe Francais De Pneumo-Cancerologie

Collaborators

• [object Object]